Drug Type Small molecule drug |
Synonyms AUPM-493 |
Target |
Action inhibitors |
Mechanism VISTA inhibitors(V-domain Ig suppressor of T-cell activation inhibitors), VSIG8 inhibitors(V-set and immunoglobulin domain containing 8 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | United States | 29 Oct 2017 | |
Neoplasms | Preclinical | India | 29 Oct 2017 |